Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 13Prostatic Neoplasms 11Leukemia 11Breast Neoplasms 11Melanoma 8Lymphoma 8Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Neoplasm Metastasis 6Myelodysplastic Syndromes 6Multiple Myeloma 6Leukemia, Myeloid, Acute 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Fallopian Tube Neoplasms 4Breast Neoplasms, Male 4Lymphoma, Follicular 3Kidney Neoplasms 3Hodgkin Disease 3Glioma 3Carcinoma, Renal Cell 3Osteosarcoma 2Neoplasms, Plasma Cell 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2

Interventions

Temozolomide 10Cyclophosphamide 10Vincristine 9Etoposide 6Doxorubicin 6Irinotecan 5palbociclib 4cabozantinib 4Topotecan 4Melphalan 4Magnetic Resonance Spectroscopy 4X-Rays 3Sirolimus 3Phantoms, Imaging 3Ifosfamide 3Gemcitabine 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2ivosidenib 2irinotecan sucrosofate 2ganitumab 2cixutumumab 2Vemurafenib 2Trabectedin 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Ewing × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00001564 2019-11-29

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
30 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡